Stay Updated
Press Releases
WASHINGTON, D.C. — Cancer patient and founder of Patients For Affordable Drugs David Mitchell joined House Oversight and Reform Committee Chairwoman Carolyn Maloney, Speaker Nancy Pelosi, congressional leaders, and advocates at a press conference today that revealed the final findings from the committee’s nearly three-year investigation into pharmaceutical pricing and business practices. The committee’s findings sharply […]
Press Releases
ICYMI: New Video Tells The Truth About COVID-19 Vaccines
WASHINGTON, D.C. — As Big Pharma is working overtime to sell the story that drug corporations saved us from COVID-19 by developing new vaccines, Patients For Affordable Drugs released a new video and fact sheet this week explaining the mRNA vaccines’ true origin story. The truth is the federal government invested billions of dollars to make […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs released an extensive fact check today that takes on Big Pharma’s lies in recent ads, which total more than $18 million this year, attacking drug pricing reforms that include allowing Medicare to negotiate lower drug prices. The fact check breaks down six false claims in pharma-funded ads, including misleading […]
Reports
Press Releases
WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, in response to the Food and Drug Administration’s approval of Mylan’s Semglee as an interchangeable biosimilar to Sanofi’s long-acting Lantus (glargine) insulin: “The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an […]
Press Releases
NEW ANALYSIS: Drug Companies Continue To Hike Prices At Will; Congress Must Act
WASHINGTON, D.C. — As the drug industry continues to hike drug prices at will, a new analysis from Patients For Affordable Drugs gives evidence of the urgent need for Congress to lower drug prices by allowing Medicare to negotiate directly with drug companies. The analysis explores more than 1,000 price hikes since the beginning of 2021 […]